CUE-CAN FROM POPULATIONS TO CELLS AND BACK: Carcinogen Unmasking and Effect characterization in early-onset
- Coordinator
- Prinses Maxima Centrum Voor Kinderoncologie BV, Netherlands
- Runs
- 1 June 2026 to 31 May 2031
- Status
- Running
- EU funding
- €7.0m
- Total cost
- €7.0m
- Partners
- 14 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101288648
What the project is doing
In the project's own words, from its summary on CORDIS.
CUE-CAN unites 14 partners from 8 European countries and Canada to reduce childhood and young adolescent cancers by preventing and detecting carcinogenic environmental exposures. Focusing on prenatal development and early childhood, the project will elucidate how external agents initiate or promote carcinogenesis and generate evidence for actionable prevention. CUE-CAN integrates epidemiological and clinical data from >2.5 million children and >10 million health records across nine cohorts, enriched with tumour molecular profiles, internal exposome measurements, geospatial exposure models and AI-driven hazard prediction.
At least 25 modifiable exposures will be prioritised, with ≥10 investigated mechanistically in human organoid and stem cell systems representing haematopoietic, neural and intestinal tissues. CRISPR-based exposure–gene interaction screens and causal inference methods will pinpoint critical developmental windows and pathways. The project will deliver interoperable, predictive exposure-risk models validated across multiple datasets and ≥10 exposure–cancer risk profiles with characteristic molecular signatures and biomarkers suitable for surveillance and targeted guidance.
CUE-CAN will co-create prevention outputs with stakeholders, including ≥5 policy recommendations, technical guidance, and stakeholder workshops to inform public health strategies and EU-level regulation. To secure long-term impact, CUE-CAN will implement a harmonised, FAIR-compliant data architecture linking cohort, registry and molecular data with ≥3 EU platforms (e.g. UNCAN.eu, EHDS, PARC), ensuring reusability and scalability.
The resulting framework will advance understanding of environmentally driven childhood cancer, equip regulators and health systems with policy-ready evidence and tools, and accelerate translation from discovery to prevention, contributing to a healthier future for Europe’s next generations. This action is part of the Cancer Mission cluster of projects on “Understanding – environmental exposure in CAYA.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Prinses Maxima Centrum Voor Kinderoncologie BV | Utrecht | Netherlands | Coordinator |
| University Health Network | Toronto | Canada | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Ethniko Kai Kapodistriako Panepistimio Athinon | Athina | Greece | Participant |
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Participant |
| Oulun Yliopisto | Oulu | Finland | Participant |
| Azienda Sanitaria Locale Roma 1 | Roma | Italy | Participant |
| European Public Health Association | Utrecht | Netherlands | Participant |
| Stichting Oncode Institute | Utrecht | Netherlands | Participant |
| Universiteit Utrecht | Utrecht | Netherlands | Participant |
| Vereniging Kinderkanker Nederland | De Bilt | Netherlands | Participant |
| Folkehelseinstituttet | Oslo | Norway | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Lunds Universitet | Lund | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI